Klotho gene and protein in human placentas according to birth weight and gestational age
Author
dc.contributor.author
Iñíguez Vila, Germán
Author
dc.contributor.author
Gallardo, Pedro
Author
dc.contributor.author
Castro, Juan José
Author
dc.contributor.author
González, René
Author
dc.contributor.author
García, Mirna
Author
dc.contributor.author
Kakarieka, Elena
Author
dc.contributor.author
San Martín, Sebastián
Author
dc.contributor.author
Johnson, María Cecilia
Author
dc.contributor.author
Mericq, Verónica
Author
dc.contributor.author
Cassorla Goluboff, Fernando
Admission date
dc.date.accessioned
2019-10-22T03:15:03Z
Available date
dc.date.available
2019-10-22T03:15:03Z
Publication date
dc.date.issued
2019
Cita de ítem
dc.identifier.citation
Frontiers in Endocrinology, Volumen 10, Issue JAN, 2019,
Identifier
dc.identifier.issn
16642392
Identifier
dc.identifier.other
10.3389/fendo.2018.00797
Identifier
dc.identifier.uri
https://repositorio.uchile.cl/handle/2250/172071
Abstract
dc.description.abstract
Introduction: Fetal growth restriction may be the consequence of maternal, fetal, or placental factors. The insulin-like growth factors (IGFs) are major determinants of fetal growth, and are expressed in the mother, fetus and placenta in most species. Previously we reported higher placental protein content of IGF-I, IGF-IR, and AKT in small (SGA) compared with those from appropriate for gestational age (AGA) placentas. The protein Klotho, has been reported in placenta and may regulate IGF-I activity. In this study we determined Klotho gene expression and protein immunostaining in term (T-SGA y T-AGA) and preterm (PT-SGA y PT-AGA) human placentas. In addition, we assessed the effect of Klotho on the IGF-IR and AKT activation induced by IGF-I. Methods: Placentas (n = 1 17) from 32 T-SGA (birth weight (BW) = −1.74 ± 0.08 SDS), 37 T-AGA (BW = 0.12 ± 0.12 SDS), 20 PT-SGA (BW = −2.08 ± 0.14 SDS), and 28 PT-AGA (BW = −0.43 ± 0.13 SDS) newborns were collected. mRNA expression by RT-PCR in the chorionic (CP) and basal (BP) plates of the placentas, and the presence of Klotho was evaluated by immunohistochemistry (integral optical density, IOD). In addition, we developed placental explants that were incubated with IGF-I in the presence or absence of Klotho. Results: We found a lower mRNA expression and protein immunoreactivity of Klotho in the CP of SGA (term and preterm) compared with AGA placentas. We also observed a significant reduction in IGF-IR tyrosine activation induced by IGF-I 10 nM when preincubated with 2.0 nM of Klotho (2.4 ± 0.5 arbitrary units vs. 1.3 ± 0.3 AU), and similar results we observed on AKT and ERK42/44 activation. Conclusion: We describe for the first time that Klotho mRNA and protein varies according to fetal growth and gestational age. In addition, Klotho appears to down-regulate the activation induced by IGF-I on IGF-IR and AKT, suggesting that Klotho may be regulating IGF-I activity in human placentas according to intrauterine fetal growth.